Roche Holding AG (FRA:RHO6)
Germany · Delayed Price · Currency is EUR 34.39
+0.10 (0.29%)
Last updated: Jul 15, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
Roche Pharmaceuticals | 43.30B | Log In | Log In | Log In | Log In | Upgrade |
Roche Pharmaceuticals Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Chugai | 2.87B | Log In | Log In | Log In | Log In | Upgrade |
Chugai Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics | 14.32B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Growth | 0.86% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.90B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.90B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.90B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.90B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Capex by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
Other | -5.34B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Roche Pharmaceuticals Capital Expenditures | 6.00B | Log In | Log In | Log In | Log In | Upgrade |
Roche Pharmaceuticals Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Chugai Capital Expenditures | 350.00M | Log In | Log In | Log In | Log In | Upgrade |
Chugai Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Capital Expenditures | 2.44B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Corporate Capital Expenditures | 78.00M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | -5.34B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | -5.34B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | -5.34B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
Other | 6.20B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 6.20B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Roche Pharmaceuticals Operating Profit | 12.34B | Log In | Log In | Log In | Log In | Upgrade |
Roche Pharmaceuticals Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Chugai Operating Profit | 3.21B | Log In | Log In | Log In | Log In | Upgrade |
Chugai Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Operating Profit | 1.95B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Corporate Operating Profit | -4.12B | Log In | Log In | Log In | Log In | Upgrade |
Corporate Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 6.20B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 6.20B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
Other | 1.90B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.90B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.90B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Switzerland | 747.00M | Log In | Log In | Log In | Log In | Upgrade |
Switzerland Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Germany | 2.93B | Log In | Log In | Log In | Log In | Upgrade |
Germany Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Rest of Europe | 10.29B | Log In | Log In | Log In | Log In | Upgrade |
Rest of Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
United States | 28.90B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Rest of North America | 889.00M | Log In | Log In | Log In | Log In | Upgrade |
Rest of North America Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Latin America | 3.25B | Log In | Log In | Log In | Log In | Upgrade |
Latin America Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Japan | 3.15B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Rest of Asia | 9.09B | Log In | Log In | Log In | Log In | Upgrade |
Rest of Asia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Africa, Australia and Oceania | 1.25B | Log In | Log In | Log In | Log In | Upgrade |
Africa, Australia and Oceania Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.90B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |